In addition, DNA from damaged tumor cells led to the activation of the cyclic GMP-AMP (cGAS)-dependent and the stimulator of IFN genes (STING)-dependent pathways, resulting in a type I-IFN-release from DCs [123]. The gene discussed is STING1; the disease is neoplasm.